Kiran Mazumdar Shaw On Salil Parekh's Selection As Infosys MD & CEO

Salil Parekh's Strategy For Infosys

Salil Parekh's Growth Mantra For Infosys

Experts Decode Whether Salil Parekh's New Mantra Works In Favour Of Infosys

SEBI may probe whistleblower charges against Infosys CEO Salil Parekh; here's what it means according to experts

Income Tax e-filing portal: Finance Ministry summons Infosys CEO Salil Parekh

Infosys appoints Salil S. Parekh as CEO and MD

Salil Parekh takes over INFOSYS as CEO & MD today | वनइंडिया हिंदी

Salil Parekh says determined to make Infosys future ready, will ramp up digital investments

Ajay Srivastava On The Appointment Of Infosys’ New MD & CEO Salil Parekh

I-T portal glitch_ Finance ministry 'summons' Infosys CEO Salil Parekh _ TV9News

Infosys CEO Salil Parekh On The Demand Environment In North America, U.K. And Europe

Businesses Forced To Factor In "Extreme Scenarios" Amid Virus: Infosys CEO, Salil Parekh

Clients have a deep connect with company; trust Infosys to deliver, says CEO Salil Parekh

Kiran Mazumdar-Shaw | Philanthropic focus on research

Kiran Mazumdar Shaw of Biocon on business outlook

Kiran Mazumdar Shaw Explains The Meaning of Atmanirbharta

Kiran Mazumdar-Shaw | Philanthropy has to be sustainable

Kiran Mazumdar-Shaw | Philanthropy can catalyse new models for government

Kiran Mazumdar-Shaw | Focus on healthcare is driven by justice and compassion

Kiran Mazumdar Shaw Backs Sikka & Team

Kiran Mazumdar Shaw’s multi-billion dollar baby

Q4 Review: Biocon's Kiran Mazumdar Shaw On Earnings & FY23 Projections

Biocon's Kiran Mazumdar-Shaw Gives A Reality Check On Ease Of Doing Business In India

Kiran Mazumdar-Shaw: Australia, New Zealand & Europe Will Be Strong Markets For Biocon

Biocon’s Kiran Mazumdar Shaw On Who’ll Win The Battle Between ‘Innovators’ And Biosimilar Makers

Economics Of A Pandemic With Kiran Mazumdar-Shaw At Bloomberg India Economic Forum 2020

Awfis Space Solutions IPO To Open May 22: Offers Co-working Spaces Nationwide | NDTV Profit

V Guard Ind Q4: Outlook On Growth | NDTV Profit

Biocon Outlook On The Biosimilar Sales | NDTV Profit

How is the Growth Wired For MSWIL? NDTV Profit

Manishi Raychaudhuri Talks Future Of Private Capex and Domestic Market Opportunities

Ideaforge's Order Book Outlook | NDTV Profit

Who is Salil Parekh?